Altered expression of α6 integrin subunit in oral squamous cell carcinoma and oral potentially malignant lesions

Oral Oncology

Volumn 34, Issue 3, 1998, Pages 204-210

  Garzino Demo, P ^a   Carrozzo, M ^a,c   Trusolino, L ^b   Savoia, P ^a   Gandolfo, S ^a   Marchisio, P C ^a,b  

^a UNIVERSITY OF TURIN   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c Clinica Odontostomatologica   (Italy)

Author keywords

Basement membrane; Integrins; Oral leucoplakia; Squamous cell carcinoma

Indexed keywords

INTEGRIN;

ARTICLE; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; LEUKOPLAKIA; MOUTH CARCINOMA; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; WOUND HEALING;

ANTIGENS, CD; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; COLLAGEN; HUMANS; IMMUNOENZYME TECHNIQUES; INTEGRIN ALPHA6; INTEGRINS; LAMININ; LEUKOPLAKIA, ORAL; MOUTH MUCOSA; MOUTH NEOPLASMS; NEOPLASM PROTEINS;

EID: 0032077937     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1368-8375(97)00059-6     Document Type: Article

References (35)

1. [1] Marchisio PC. Integrins and tissue organization. Advances in Neuroimmunology 1991;1:214-234.
2. [2] Rouslahti E, Giancotti F. Integrins and tumors cell disseminations. Cancer Cell 1989;1(4):119-126.
3. [3] Hynes RO. Integrins: versatility, modulation, and signaling in cell adhesion. Cell 1992;69:11-25.
4. [4] Clark EA, Brugge JG. Integrins and signal transduction pathways: the road taken. Science 1995;268(5208):233-239.
5. [5] Liebert M, Wedemeyer G, Stein JA, et al. The monoclonal antibody BQ 16 identifies the α6β4 integrin on bladder cancer. Hybridoma 1993;12:67-80.
6. [6] Bonkhoff H, Stein U, Remberg K. Differential expression of α6 and α2 very late antigen integrin in the normal, hyperplastic and neoplastic prostate: simultaneous demonstration of cell surface receptors and their extracellular ligands. Human Pathology 1993;24:243-248.
7. [7] Savoia P, Trusolino L, Pepino E, Cremona O, Marchisio PC. Expression and topography of integrins and basement membrane proteins in epidermal carcinomas: basal but not squamous cell carcinoma display loss of α6β4 and BM-600/nicein. Journal of Investigative Dermatology 1993;101(3):352-358.
8. [8] Pignatelli M, Smith MEF, Bodmer WF. Low expression of collagen receptors in moderate and poorly differentiated colorectal adenocarcinomas. British Journal of Cancer 1990;61:636-638.
9. [9] Koretz K, Schlag P, Boumsell L, Moller P. Expression of VLA-alpha2, VLA-alpha6, and VLA-beta1 chains in normal mucosa and adenomas of the colon, and in colocarcinoma and their liver metastasis. American Journal of Pathology 1991;148:741-750.
10. [10] Zutter M, Mazoujian M, Santoro SA. Decreased expression of integrin adhesive protein receptors in adenocarcinoma of breast. American Journal of Pathology 1990;137:863-870.
11. [11] D'Ardenne AJ, Richman PI, Orthonne MA, McAuly AE., Jordan S. Coordinate expression of alpha6 integrin laminin receptor subunit and laminin in breast cancer. Journal of Pathology 1991;165:213-220.
12. [12] Pignatelli M, Hanby AM, Stamp GWH. Low expression of beta1, alpha2 and alpha3 subunits of VLA integrins in malignant mammary tumors. Journal of Pathology 1991;165:25-32.
13. [13] Koukolis GK, Virtanen I, Korhonen M, Laitinen L, Quaranta V, Gould VA. Immunohistochemical localization of integrins in the normal, hyperplastic and neoplastic breast. American Journal of Pathology 1991;139:787-799.
14. [14] Friederichs K, Ruiz P, Folker F, Gille I, Terpe HJ, Imhof BA. High expression level of α6 integrin in human breast carcinoma is correlated with reduced survival. Cancer Research 1995;55: 901-906.
15. [15] Hall PA, Coates P, Lemoine NR, Horthons MA. Characterization of integrin chains in normal and neoplastic human pancreas. Journal of Pathology 1991;108:523-532.
16. [16] Weinel R, Rosendahl A, Pinshmidt E, Kisker O, Simon B, Santoso S. The α6 integrin receptor in pancreatic carcinoma. Gastroenterology 1995;108:523-532.
17. [17] Serini G, Trusolino L, Saggiorato E, et al. Changes in integrin and E-cadherin expression in neoplastic versus normal thyroid tissue. Journal of the National Cancer Institute 1996;88: 442-449.
18. [18] Hormia M, Ylanne J, Virtanen I. Expression of integrins in human gingiva. Journal of Dental Research 1990;69:1817-1823.
19. [19] Jones J, Sugiyama M, Watt FM, Speight PM. Integrin expression in normal, hyperplastic, dysplastic and malignant oral epithelium. Journal of Pathology 1993;169:235-243.
20. [20] Kimmel KA, Carely TE. Altered expression in squamous cell carcinoma cells of an orientation restricted epithelial antigen detected by monoclonal antibody A9. Cancer Research 1986;46: 3614-3623.
21. [21] Wolf GT, Carey TE, Schaltz SP, et al. Altered antigen expression predicts outcome in squamous cell carcinoma of the head and neck. Journal of the National Cancer Institute 1990;82:1566-1572.
22. [22] Van Waes C, Kozarsky KF, Warren AB, et al. The A9 antigen associated with aggressive human squamous cell carcinoma is structurally and functionally similar to the newly defined integrin α6β4. Cancer Research 1991;51:2395-2402.
23. [23] Downer CS, Watt FM, Speight PM. Loss of α6 and β4 integrin subunits coincides with loss of basement membrane components in oral squamous cell carcinomas. Journal of Pathology 1993;171: 183-190.
24. [24] Kajiji S, Tamura RL, Quaranta V. A novel integrin (alphaE-beta4) from human epithelial cells suggests a fourth family of integrin receptors. The EMBO Journal 1989;8:673-680.
25. [25] De Luca M, Tamura RL, Kajiji S, et al. Polarized integrin mediates keratinocytes adhesion to basal lamina. Proceedings of the National Academy of Sciences of the USA 1990;87: 6888-6892.
26. [26] Karabulut A, Reibel J, Therkildsen MH, Praetorius F, Nielsen HW, Dabelsteen E. Observer variability in the histologic assessment of oral premalignant lesions. Journal of Oral Pathology and Medicine 1995;24:198-200.
27. [27] Scully C, Burkhardt A. Tissue markers of potentially malignant human oral epithelial lesions. Journal of Oral Pathology and Medicine 1993;22:246-256.
28. [28] Verrando P, Hsi BL, Yeh CJ, Pisani A, Serieys N, Orthonne JO. Monoclonal antibody GB3, a new probe for the study of human basement membrane and hemidesmosomes. Experimental Cell Research 1987;170:116-118.
29. [29] Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;277:680-685.
30. [30] Gomez M, Navatro P, Quintanilla M, Cano A. Expression of α6β4 integrin increases during malignant conversion of mouse epidermal keratinocytes: association of β4 subunit to the cytokeratin fraction. Experimental Cell Research 1992;201:250-261.
31. [31] Tennenbaum T, Weiner AK, Belanger AJ, Glick AB, Hennings H, Yuspa SH. The suprabasal expression of α6β4 integrin is associated with a high risk for malignant progression in mouse skin carcinogenesis. Cancer Research 1993;53:4803-4810.
32. [32] Kosmehl H, Berndt A, Katenkamp D, et al. Integrin receptors and their relationship to cellular proliferation and differention of oral squamous cell carcinoma. A quantitative immunohistochemical study. Journal of Oral Pathology and Medicine 1995;24:343-348.
33. [33] Kurpakus MA, Quaranta V, Jones JCR. Surface relocation of α6β4 integrin and assembly of hemidesmosomes in an in vitro model of wound healing. Journal of Cell Biology 1991;115: 1737-1750.
34. [34] Carico EC, French D, Bucci B, Falcioni R, Vecchione A, Mariani-Constantini R. Integrin β4 expression in the neoplastic progression of cervical epithelium. Gynecologic Oncology 1993;49:61-66.
35. [35] Becker J, Schuppan D. Altered expression of extracellular matrix proteins and integrins in oral lichen planus (OLP). Journal of Oral Pathology and Medicine 1995;24:159-164.